Edition:
United Kingdom

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

1.11USD
4:23pm BST
Change (% chg)

$-0.01 (-0.89%)
Prev Close
$1.12
Open
$1.12
Day's High
$1.12
Day's Low
$1.10
Volume
21,172
Avg. Vol
181,022
52-wk High
$3.34
52-wk Low
$0.43

Latest Key Developments (Source: Significant Developments)

Acasti Pharma grants Chinese pharma co exclusive license to commercialize CaPre in China​
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Acasti Pharma Inc :Acasti Pharma Inc - ‍clarifies term of proposed strategic partnership with China pharmaceutical company​.Acasti - Under proposed term, Chinese pharmaceutical co to be granted exclusive license to commercialize CaPre in certain Asian countries including China​.  Full Article

Acasti Pharma ‍enters into non-binding agreement with China-based pharma
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Acasti Pharma Inc :Acasti Pharma Inc - ‍entered into a non-binding term sheet with a China-based pharmaceutical company​.Acasti Pharma - ‍if definitive agreement is reached, signed, term sheet contemplates co would receive an upfront payment of us$8 million upon signing.Acasti Pharma Inc - ‍if definitive agreement is reached & signed, co would also receive potential additional milestone payments in excess of $125 million​.  Full Article

Acasti Pharma says is offering 11.7 mln common shares‍​
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Acasti Pharma Inc :Says it is offering 11.7 million common shares‍​ - SEC Filing.  Full Article

Acasti Pharma reports Q2 loss per share C‍$0.31​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Acasti Pharma Inc :Acasti Pharma reports second quarter FY 2018 financial results.Acasti Pharma Inc qtrly loss per share C‍$0.31​.  Full Article

BRIEF-Acasti Pharma Prices $10 Million Underwritten Offering

* ACASTI PHARMA - ENTERED INTO UNDERWRITING AGREEMENT WITH MACKIE RESEARCH CAPITAL CORP TO SELL 9.5 MILLION UNITS OF CO AT A PRICE OF CDN$1.05 PER UNIT Source text for Eikon: Further company coverage: